Recent Study: Urological Disorders Therapeutics to 2016

Sept. 1, 2010 - PRLog -- GBI Research's Therapeutic Analysis report, "Urological Disorders Therapeutics to 2016 - Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Markets", provides in-depth analysis of unmet needs, drivers and barriers that impact the global urological disorders market. This pharmaceutical and healthcare report analyzes the markets for urological disorders in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, prices and volumes are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts. GBI Research finds that the urological disorders market will continue to grow moderately, largely due to increase in aging population and increase in awareness of indications such as UI, BPH and UTI. The prime reason for slow growth of the market will be a series of patent expiries of the top selling blockbusters across all the markets. Particularly in BPH, the entry of generics coupled with the patent expirations of Flomax, Uroxatral (in US) and Avodart, three of the best selling drugs in the BPH market, is expected to pull down the market in terms of value in the future. However, the patent expiries will not result in significant market value loss due to the low price differential between branded and generics.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

* Annualized market data for the urological disorders market from 2001 to 2009, forecast forward to 2016.
* Analysis of the leading therapeutic segments, including Urinary Incontinence (UI), Benign Prostatic Hyperplasia (BPH) and Urinary Tract Infections (UTI).
* Analysis of the urological disorders market in the leading geographies of the world, which include the US (United States), the UK (United Kingdom), Germany, France, Italy, Spain and Japan.
* Market characterization of the urological disorders market, including market size, annual cost of therapy and treatment usage patterns.
* Key drivers and barriers that have a significant impact on the market.
* Coverage of pipeline molecules in various phases of drug development.
* Competitive benchmarking of leading companies. The key companies studied in this report are Allergen Inc, Astellas Pharma, Pfizer Inc, Novexel SA, Eli Lilly and Company, GSK, Sanofi-- Aventis, Johnson and Johnson and Protox Therapeutics, Inc.
* Key M&A activities, licensing agreements that have taken place between 2004 and mid-2010 in the global urological disorders market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to

* Align your product portfolio to the markets with high growth potential.
* Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth.
* Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules with more efficiency and better safety.
* Develop key strategic initiatives by understanding the key focus areas of leading companies.
* Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.

For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/80737_urological_disorders_the...

Partial Table of Contents:

1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 7
2 Global Urological Disorders Market: Introduction 10
2.1 GBI Research Report Guidance 11
3 Global Urological Disorders Market: Market Overview 12
3.1 Introduction 12
3.2 Revenue Forecasts for the Global Urological Disorders Market 13
3.2.1 Sales Value 13
3.2.2 Annual Cost of Therapy 14
3.2.3 Treatment Usage Patterns 15
3.2.4 Generics' Share in the Global Urological Disorders Market 20
3.3 Urological Disorders Market Drivers 22
3.3.1 Steady Increase in the UI and BPH Prevalence Population 22
3.3.2 Rapid Uptake of Branded Products due to Better Efficacy in BPH 22
3.3.3 Patent Expiries of Branded Drugs Will Make Them More Affordable 22
3.4 Urological Disorders Market Restraints 23
3.4.1 Unwillingness to Seek Medical Help for UI 23
3.4.2 Patent Expiries of Major Blockbusters Including Detrol, Flomax, Levaquin, Avodart,  and Uroxatral Pose a Threat to Market Revenues 23
3.4.3 Non Pharmacological Therapy Recommended for UI and BPH 23
4 Global Urological Disorders Market: Therapeutic Landscape 24
4.1 Benign Prostatic Hyperplasia Market 24
4.1.1 Introduction 24
4.1.2 Sales Value 24
4.1.3 Annual Cost of Therapy 26
4.1.4 Treatment Usage Patterns 27
4.1.5 Market Share by Geography 32
4.1.6 Generics' Share of the Global BPH Market 35
4.2 Urinary Incontinence (UI) Market 36
4.2.1 Introduction 36
4.2.2 Sales Value 37
4.2.3 Annual Cost of Therapy 39
4.2.4 Treatment Usage Patterns 40
4.2.5 Market Share by Geography 45
4.2.6 Generics' Share in the Global UI Market 49
4.3 Urinary Tract Infections Market 51
4.3.1 Introduction 51
4.3.2 Sales Value 51
4.3.3 Annual Cost of Therapy 53
4.3.4 Treatment Usage Patterns 54
4.3.5 Market Share by Geography 59
4.3.6 Generics' Share of the Global UTI Market 62

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=8073...

About GBI Research

GBI Research provides industry-leading global business intelligence solutions. Their products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports each year across a wide range of industries. These reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from their expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia.  View more research from GBI Research at http://www.fastmr.com/catalog/publishers.aspx?pubid=1016

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.